<?xml version="1.0" encoding="utf-8"?>
<journal>
<title>Journal of Surgery and Trauma</title>
<title_fa>نشریه جراحی و تروما</title_fa>
<short_title>J Surg Trauma</short_title>
<subject>Medical Sciences</subject>
<web_url>http://jsurgery.bums.ac.ir</web_url>
<journal_hbi_system_id>1</journal_hbi_system_id>
<journal_hbi_system_user>admin</journal_hbi_system_user>
<journal_id_issn>2345-4873</journal_id_issn>
<journal_id_issn_online>2345-4873</journal_id_issn_online>
<journal_id_pii></journal_id_pii>
<journal_id_doi>10.61882/jsurgtrauma</journal_id_doi>
<journal_id_iranmedex></journal_id_iranmedex>
<journal_id_magiran></journal_id_magiran>
<journal_id_sid></journal_id_sid>
<journal_id_nlai></journal_id_nlai>
<journal_id_science></journal_id_science>
<language>en</language>
<pubdate>
	<type>jalali</type>
	<year>1393</year>
	<month>12</month>
	<day>1</day>
</pubdate>
<pubdate>
	<type>gregorian</type>
	<year>2015</year>
	<month>3</month>
	<day>1</day>
</pubdate>
<volume>3</volume>
<number>1</number>
<publish_type>online</publish_type>
<publish_edition>1</publish_edition>
<article_type>fulltext</article_type>
<articleset>
	<article>


	<language>en</language>
	<article_id_doi></article_id_doi>
	<title_fa></title_fa>
	<title>Treatment of recurrent pterygium with topical administration of interferon alpha-2b: A case report </title>
	<subject_fa>چشم</subject_fa>
	<subject>Ophthalmology</subject>
	<content_type_fa>گزارش مورد</content_type_fa>
	<content_type>Case Report</content_type>
	<abstract_fa></abstract_fa>
	<abstract>&lt;table align=&quot;left&quot; cellpadding=&quot;0&quot; cellspacing=&quot;0&quot; hspace=&quot;0&quot; vspace=&quot;0&quot;&gt;
	&lt;tbody&gt;
		&lt;tr&gt;
			&lt;td align=&quot;left&quot;&gt;
			&lt;p&gt;Pterygium is characterized by an elastic degeneration of the conjunctiva that extends across the limbos and invades the cornea. The recurrence rate is varied from 25-80% after primary closure to 6% with free conjunctival and Iimbal grafts. Several adjunctive therapies have been investigated for recurrent pte&amp;not;rygium. This article presents a 52-year-old athletic man who was seen for evaluation of a recurrent lesion in his right eye and treated with topical administration of IFN-&amp;alpha;-2b (Intron A, Schering Plough, Kenilworth, NJ), 1 million units/mL 4 times a day as eye drops. &amp;nbsp;&lt;/p&gt;
			&lt;/td&gt;
		&lt;/tr&gt;
	&lt;/tbody&gt;
&lt;/table&gt;
&lt;div style=&quot;clear: both;&quot;&gt;&lt;/div&gt;</abstract>
	<keyword_fa></keyword_fa>
	<keyword>Recurrent pterygium, Interferon alpha-2b,  Topical administration</keyword>
	<start_page>30</start_page>
	<end_page>32</end_page>
	<web_url>http://jsurgery.bums.ac.ir/browse.php?a_code=A-10-65-1&amp;slc_lang=en&amp;sid=1</web_url>


<author_list>
	<author>
	<first_name>Mohammad Hossien</first_name>
	<middle_name></middle_name>
	<last_name>Davari</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>mhd_1337@yahoo.com</email>
	<code>10031947532846003244</code>
	<orcid>10031947532846003244</orcid>
	<coreauthor>Yes
</coreauthor>
	<affiliation>Birjand University of Medical Sciences</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Hoda</first_name>
	<middle_name></middle_name>
	<last_name>Ghitasi</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>hoda24masoud@yahoo.com</email>
	<code>10031947532846003245</code>
	<orcid>10031947532846003245</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Hospital Duran I Reynolds</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Esmat</first_name>
	<middle_name></middle_name>
	<last_name>Davari</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>mhd_1337@yahoo.com</email>
	<code>10031947532846003246</code>
	<orcid>10031947532846003246</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Birjand University of Medical Sciences</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


</author_list>


	</article>
</articleset>
</journal>
